Markets

  1. Home
Market Nav

News Details

08/05/2025 15:37

Lupin Ltd. - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Lupin Receives Approval from U.S. FDA for Raltegravir Tablets USP, 600 mg.